Received Aug 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 95R7C | — |
38 year old received a pediatric dose; 38 year old received a pediatric dose; pediatric dose that had been administered had expired; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 38-year-old male patient who received HAV (Havrix pediatric) (batch number 95R7C, expiry date 05-MAY-2025) for prophylaxis. On 25-JUL-2025, the patient received Havrix pediatric. On 25-JUL-2025, an unknown time after receiving Havrix pediatric, the patient experienced underdose (Verbatim: 38 year old received a pediatric dose), adult use of a child product (Verbatim: 38 year old received a pediatric dose) and expired vaccine used (Verbatim: pediatric dose that had been administered had expired). The outcome of the underdose, adult use of a child product and expired vaccine used were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-JUL-2025 A pharmacy technician called to inform that earlier that day, a patient received two doses of Havrix, he received a pediatric dose and he was fine, and then another adult dose in the other arm, batch number 2345B, expiry date 02nd February 2026. Reporter realized during the call that the pediatric dose that had been administered had expired back which led to expired vaccine used, adult use of a child product and underdose. No further details provided by reporter.